Vitamin K Antagonism of Coumarin Intoxication in the Rat

Summary

An in vitro system which expresses all enzyme activities related to vitamin K-dependent carboxylation of blood clotting factors was prepared from livers of rats overdosed with warfarin, difenacoum and dicumarol respectively. In this system, the activities of the two pathways that are known to produce active reduced vitamin K₁ cofactor for the carboxylation reaction were measured. Also the ability of high concentrations of vitamin Kx to overcome inhibition of clotting factor synthesis was studied. In the systems prepared from livers of warfarin and difenacoum intoxicated rats, pathway I was inactive. Vitamin K epoxide reductase was also inactive which strongly suggests that this enzyme catalyzes the activity of pathway I in vivo. Reduction of vitamin by pathway II bypassed the inactive pathway I and resulted in carboxylation activity. This pathway therefore mediates the antidotic effect of vitamin K₁ in the coumarin intoxicated liver. In the in vitro system prepared from dicumarol intoxicated livers the activity of pathway I was not significantly affected. Dicumarol however was a strong inhibitor when added to liver microsomes in vitro.

Key words

Coumarin - Vitamin K - Anticoagulants

• References

• 1 Suttie JW, Vitamin K. In The Fat-Soluble Vitamins, Handbook of Lipid Research. Volume 2 DeLuca HF. (ed.) Plenum Press; New York: 1978: 211-277
• 2 Suttie JW, Jackson CM. Prothrombin structure, activation, and biosynthesis. Physiol Rev 1977; 57: 1-70
• 3 O’Reilly RA. Vitamin K and the oral anticoagulant drugs. Ann Rev Med 1976; 27: 245-261
• 4 Wallin R, Martin LF. Vitamin K-dependent carboxylation and vitamin K metabolism in liver; effects of warfarin. J Clin Invest 1985; 76: 1879-1884
• 5 Wallin R, Martin LF. Coumarin intoxication and vitamin K antagonism in rat and human liver; design of an in vitro system that mimics the in vivo situation. Submitted for publication 1985
• 6 Fasco MJ, Principe LM. R- and S-warfarin inhibition of vitamin K and vitamin K2, 3-epoxide reductase activities in the rat. J Biol Chem 1982; 257: 4894-4901
• 7 Wallin R. Vitamin K antagonism and coumarin anticoagulant drugs. A study of an enzymatic pathway in rat liver that is responsible for the antagonistic effect. . Thromb Haemostas 1985; 54: 150
• 8 Wallin R, Hutson S. Vitamin K-dependent carboxylation; evidence that at least two microsomal dehydrogenases reduce vitamin Kx to support carboxylation. J Biol Chem 1982; 257: 1583-1586
• 9 O’Reilly RA, Aggeler PM. Convert anticoagulant ingestion: Study of 25 patients and review of world literature. Medicine 1976; 55: 389-399
• 10 Van Der Meer J, Hemker HC, Loeliger EA. Pharmacological aspects of vitamin Kj. A clinical and experimental study in man. Thrombos Diathes Haemorrh Suppl 1968; 19: 61-63
• 11 Park BK, Leek JB. A comparison of vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit. Biochem Pharmacol 1982; 31: 3635-3639
• 12 Suttie JW, Hageman JW, Lehrman SR, Rich DH. Vitamin K-dependent carboxylase. Development of a peptide substrate. J Biol Chem 1976; 251: 5827-5830
• 13 Esmon CT, Suttie JW. Vitamin K-dependent carboxylase. Solubilization and properties. J Biol Chem 1976; 251: 6238-6243
• 14 Mayo Clinic Laboratory Manual of Hemostasis. Thomson-Didishein-Owen Bowie. (eds.) W B Saunders Company; Philadelphia, London, Toronto: 1971: 93-129
• 15 Nelsestuen GL, Suttie JW. The carbohydrate of bovine prothrombin. J Biol Chem 1972; 247: 6096-6102
• 16 Sadowski JA, Esmon CT, Suttie JW. Vitamin K-dependent carboxylase: Requirement of the rat liver microsomal enzyme system. J Biol Chem 1970; 251: 2770-2779
• 17 Tishler M, Fieser LF, Wendler NL. Hydro oxido and other derivatives of vitamin Kx and related compounds. J Am Chem Soc 1940; 62: 2866-2871
• 18 Shah DV, Suttie JW. Vitamin K-dependent carboxylase: increased activity in a hypoprothrombinemia state. Arch Biochem Biophys 1978; 191: 571-577
• 19 Witlon DS, Sadowski JA, Suttie JW. Mechanism of coumarin action: Significance of vitamin K epoxide reductase inhibition. Biochemistry 1978; 17: 1371-1977
• 20 Hildebrandt EF, Suttie JW. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver. Biochemistry 1982; 27: 2406-2411
• 21 Caldwell PT, Ren P, Bell RG. Warfarin and metabolism of vitaminK₁ . Biochem Pharmacol 1974; 23: 3353-3362
• 22 Bell RG, Stark P. Inhibition of prothrombin synthesis and epoxida-tion of vitamin K2 by anticoagulants in vitro. Biochem Biophys Res Commun 1976; 72: 619-625
• 23 Leek JB, Park BK. A comparative study of the effects of warfarin and brodifacoum on the relationship between vitamin K, metabolism and clotting factor activity in warfarin-susceptible and warfarin-resistant rats. Biochem Pharmacol 1981; 30: 123-128
• 1 Ren P, Laliberte RE, Bell RG. Effects of warfarin, phenylin-danedione, tetrachloropyridinol, and chloro-vitamin Kj on prothrombin synthesis and vitamin K metabolism in normal and Warfarin-resistant rats. Mol Pharmacol 1974; 10: 373-380
• 25 O’Reilly RA, Aggeler PM, Leong LS. Studies on the coumarin anticoagulant drugs: a comparison of the pharmacodynamics of dicumarol and warfarin in man. Thrombos Diathes Haemorrh 1964; 11: 1-22
• 26 Zimmerman A, Matschiner JT. Biochemical basis of hereditary resistance to warfarin in the rat. Biochem Pharmacol 1974; 23: 1033-1040
• 27 Backmann UA, Sullivan TJ. Dispositional and pharmacodynamic characteristics of brodifacoum in warfarin-sensitive rats. Pharmacol 1983; 27: 281-288
• 28 Fasco MJ, Kaminisky LS. R- and S-warfarin and metabolites as probes of vitamin K₁ epoxide reductase. In Vitamin K Metabolism and Vitamin K-Dependent-Proteins: Suttie J W (ed.). University Park Press 1979; 366-369
• 29 Park BK, Leek JB. A comparison of vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit. Biochem Pharmacol 1982; 31: 3635-3639
• 30 Ernster L, Lind C, Rase B. A study of the DT-diaphorase activity in warfarin-resistant rats. Eur J Biochem 1972; 25: 198-206